Yuelin Li, PhD

Attending Behavioral Scientist
Epidemiology & Biostatistics
Directory
Epidemiology
Biostatistics
Health Outcomes
Computational Oncology
Administrative Resources
Career Opportunities
Educational Opportunities
Departmental Newsletter

Yuelin Li, PhD

Attending Behavioral Scientist
Share
Share
Yuelin Li, Attending Behavioral Scientist

Office Phone

646-888-0047

Email

[email protected]

Education

Columbia University

Current Research Interests

Dr. Li is a behavioral statistician with a joint appointment in the Department of Psychiatry & Behavioral Sciences and the Department of Epidemiology and Biostatistics. His expertise is in Bayesian Item Response Theory and Bayesian Multilevel Modeling. His current research focuses on Bayesian Nonparametric methods in psychology as well as Patient-Reported Outcomes data analysis using Machine Learning analytics, including Dirichlet Process Mixture Modeling (PMID: 31217637) on psychological symptom clusters for patients with advanced/terminal cancer near the end of life and Latent Dirichlet Allocation to score patients’ quality of life (PMID: 30798421). Clinicians are no longer restricted by conventional QOL surveys which rely on fixed (and often lengthy) surveys that routinely neglect each patient’s idiosyncratic goals and priorities. Patients’ goals can now be incorporated to enhance conventional data from fixed-length QOL measures. Dr. Li also works on making these revolutionary ideas accessible to behavioral scientists in his tutorials on Bayesian psychometric methods (PMID: 29424559, 22362655, 27193366).

Publications

Selected peer-reviewed publications:

  1. Li Y and Baron J.  Behavioral Research Data Analysis in R.  Springer.
  2. Li Y and Baser R.  Using R and WinBUGS to fit a generalized partial credit model for developing and evaluating patient-reported outcomes assessments. Stat Med. 15;31(18):2010-26. doi: 10.1002/sim.4475.
  3. Li Y, Rapkin B.  Classification and regression tree uncovered hierarchy of psychosocial determinants underlying quality-of-life response shift in HIV/AIDS.  J Clin Epidemiol. 2009 Nov;62(11):1138-47. doi:10.1016/j.jclinepi.2009.03.021.
  4. Ahles TA, Saykin AJ, McDonald BC, Li Y, Furstenberg CT, Hanscom BS, Mulrooney TJ, Schwartz GN, Kaufman PA. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.  J Clin Oncol. 2010 Oct 10;28(29):4434-40. doi: 10.1200/JCO.2009.27.0827.
  5. Ostroff JS, Burkhalter JE, Cinciripini PM, Li Y, et al. (in press). Randomized Trial of a Pre-Surgical Scheduled Reduced Smoking Intervention for Patients Newly Diagnosed with Cancer.

Visit PubMed for a full listing of Yuelin Li’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Yuelin Li discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures